Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer|TNBC - Triple-Negative Breast Cancer|Residual Disease
Interventions: BIOLOGICAL: α-lactalbumin vaccine|BIOLOGICAL: Zymosan
Sponsor: George T. Budd
Collaborators: United States Department of Defense|Anixa Biosciences, Inc.